Prevalence and reliability of self-reported authorship disclosures in Otolaryngology-Head and Neck Surgery

Otolaryngology - Head and Neck Surgery

Volumn 141, Issue 3, 2009, Pages 311-315

  Bhattacharyya, Neil ^a,b   Lin, Harrison W ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFLICT OF INTEREST; HEAD AND NECK SURGERY; INTERPERSONAL COMMUNICATION; OTORHINOLARYNGOLOGY; PUBLICATION; RELIABILITY; SELF REPORT; WRITING;

ACADEMIES AND INSTITUTES; AUTHORSHIP; COHORT STUDIES; CONFLICT OF INTEREST; DISCLOSURE; HUMANS; OTOLARYNGOLOGY; OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES; PERIODICALS AS TOPIC; QUESTIONNAIRES; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 68949207816     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2009.06.010     Document Type: Article

References (21)

1. Wilson D. Harvard Medical School in ethics quandary (March 2, 2009). http://www.nytimes.com/2009/03/03/business/03medschool.html (accessed March 9, 2009)
2. Bekelman J.E., Li Y., and Gross C.P. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289 (2003) 454-465
3. Stelfox H.T., Chua G., O'Rourke K., et al. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med 338 (1998) 101-106
4. Rochon P.A., Gurwitz J.H., Simms R.W., et al. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med 154 (1994) 157-163
5. Friedberg M., Saffran B., Stinson T.J., et al. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA 282 (1999) 1453-1457
6. Djulbegovic B., Lacevic M., Cantor A., et al. The uncertainty principle and industry-sponsored research. Lancet 356 9230 (2000) 635-638
7. Wahlbeck K., and Adams C. Beyond conflict of interest. Sponsored drug trials show more-favourable outcomes. BMJ 318 7181 (1999) 465
8. Perlis C.S., Harwood M., and Perlis R.H. Extent and impact of industry sponsorship conflicts of interest in dermatology research. J Am Acad Dermatol 52 (2005) 967-971
9. Thompson D. Understanding financial conflicts of interest. N Engl J Med 329 (1993) 573-576
10. Rosenfeld R.M. Editorial: Disclosure. Otolaryngol Head Neck Surg 139 (2008) 483-485
11. Policy statement. disclosure and continuing medical education activities. Otolaryngol Head Neck Surg 127 (2002) 7
12. Otolaryngology-Head and Neck Surgery. Author guidelines (January 2009). http://www.elsevier.com/framework_products/promis_misc/otoguidelines.pdf (accessed March 9, 2009)
13. DeAngelis C.D., and Fontanarosa P.B. Impugning the integrity of medical science: the adverse effects of industry influence. JAMA 299 (2008) 1833-1835
14. Angell M. Industry-sponsored clinical research: a broken system. JAMA 300 (2008) 1069-1071
15. Turner E.H., Matthews A.M., Linardatos E., et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 358 (2008) 252-260
16. Psaty B.M., and Kronmal R.A. Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation. JAMA 299 (2008) 1813-1817
17. Ross J.S., Hill K.P., Egilman D.S., et al. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA 299 (2008) 1800-1812
18. Bodenheimer T. Uneasy alliance-clinical investigators and the pharmaceutical industry. N Engl J Med 342 (2000) 1539-1544
19. Kjaergard L.L., and Als-Nielsen B. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ 325 7358 (2002) 249
20. Hussain A., and Smith R. Declaring financial competing interests: survey of five general medical journals. BMJ 323 7307 (2001) 263-264
21. Gross C.P., Gupta A.R., and Krumholz H.M. Disclosure of financial competing interests in randomised controlled trials: cross sectional review. BMJ 326 7388 (2003) 526-527